Evidence map›Paper›PMID 27399657›Full record

ArticleMolecules (Basel, Switzerland)2016

The Pleiotropic Antibacterial Mechanisms of Ursolic Acid against Methicillin-Resistant Staphylococcus aureus (MRSA).

Chao-Min Wang, Yun-Lian Jhan, Shang-Jie Tsai, Chang-Hung Chou

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Almond [Molecules (Basel, Switzerland) · 2023
    Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Ursolic Acid Derivatives as Potential Agents AgainstPathogens (Basel, Switzerland) · 2019
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Chao-Min WangResearch Center for Biodiversity, China Medical University, Taichung 40402, Taiwan. wangchaomin@mail.cmu.edu.tw.
Yun-Lian JhanResearch Center for Biodiversity, China Medical University, Taichung 40402, Taiwan. ah_giu@yahoo.com.tw.
Shang-Jie TsaiResearch Center for Biodiversity, China Medical University, Taichung 40402, Taiwan. csungjay@yahoo.com.tw.
Chang-Hung ChouResearch Center for Biodiversity, China Medical University, Taichung 40402, Taiwan. choumasa@mail.cmu.edu.tw.
China Medical University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1)

backgroundSeveral triterpenoids were found to act synergistically with classes of antibiotic, indicating that plant-derived chemicals have potential to be used as therapeutics to enhance the activity of antibiotics against multidrug-resistant pathogens. However, the mode of action of triterpenoids against bacterial pathogens remains unclear. The objective of this study is to evaluate the interaction between ursolic acid against methicillin-resistant Staphylococcus aureus (MRSA); (2)

methodsThe ability of ursolic acid to damage mammalian and bacterial membranes was examined. The proteomic response of methicillin-resistant S. aureus in ursolic acid treatment was investigated using two-dimensional (2D) proteomic analysis; (3)

resultsUrsolic acid caused the loss of staphylococcal membrane integrity without hemolytic activity. The comparison of the protein pattern of ursolic acid-treated and normal MRSA cells revealed that ursolic acid affected a variety of proteins involved in the translation process with translational accuracy, ribonuclease and chaperon subunits, glycolysis and oxidative responses; (4)

conclusionThe mode of action of ursolic acid appears to be the influence on the integrity of the bacterial membrane initially, followed by inhibition of protein synthesis and the metabolic pathway. These findings reflect that the pleiotropic effects of ursolic acid against MRSA make it a promising antibacterial agent in pharmaceutical research.

Indexed as

AnimalsAnti-Bacterial AgentsBacterial ProteinsCell MembraneMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsModels, BiologicalMolecular StructureProtein BiosynthesisProtein Interaction MappingProtein Interaction MapsProteomicsSheepTriterpenesUrsolic AcidAnti-Bacterial AgentsBacterial ProteinsTriterpenesUrsolic Acidmethicillin-resistant Staphylococcus aureus (MRSA)two-dimensional gel electrophoresis (2DE)ursolic acid

Identifiers

PMID27399657
PMCPMC6273082
OpenAlexW2468143765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.